Citigroup gives the highest Wall Street price target, bullish on Lear Corporation (LEA.US) navigating through the automotive industry cyclic headwinds.
Citigroup maintains a "buy" rating on Lear Corporation (LEA.US) and raises its target price from $136 to $146.
Citigroup maintains its "buy" rating on Lear Corporation (LEA.US) and raises its target price from $136 to $146. This move indicates that despite the challenging automotive supply cycle, the bank remains confident in the company's long-term prospects. Citigroup's bullish stance makes it one of the highest target prices given by Wall Street for Lear Corporation, although the overall market consensus remains relatively conservative.
Lear Corporation's third quarter 2025 earnings report shows an adjusted earnings per share of $2.79 and revenue of $5.7 billion, slightly higher than some expectations. The company generated $444 million in operating cash flow and $307 million in free cash flow during the quarter. Additionally, through its ongoing stock repurchase program, the company repurchased approximately $1 billion worth of shares in the quarter. As of the end of the quarter, Lear Corporation had close to $3 billion in total liquidity, providing support for its capital returns and operational flexibility.
On the other hand, Morgan Stanley downgraded Lear Corporation's rating from "overweight" to "equal weight" on December 8, with a target price of $112, reflecting the bank's cautious stance on the cyclical nature and demand volatility of the automotive production.
Lear Corporation is a global leader in automotive technology, designing, developing, manufacturing, and providing advanced seating and electrical systems for original equipment manufacturers (OEMs) worldwide.
In September of this year, Palantir announced an extension of its partnership with Lear Corporation (LEA.US) for five years, further applying artificial intelligence technology to manufacturing operations. Under the new agreement, Lear Corporation will expand its use of Palantir Foundry and apply Palantir's Warp Speed manufacturing operating system and artificial intelligence platform to its global manufacturing operations.
Related Articles

A-share market midday report | Market suddenly plunges, Shanghai Composite Index and Shenzhen Composite Index both turn green! The lithium battery industry chain strengthens against the trend.

Johnson & Johnson's subcutaneous injection dual therapy approved for marketing in China, reducing administration time to approximately 5 minutes.

Central China: The overall importance of animated films in box office receipts is becoming increasingly clear, with the influence of domestic animated films on the rise.
A-share market midday report | Market suddenly plunges, Shanghai Composite Index and Shenzhen Composite Index both turn green! The lithium battery industry chain strengthens against the trend.

Johnson & Johnson's subcutaneous injection dual therapy approved for marketing in China, reducing administration time to approximately 5 minutes.

Central China: The overall importance of animated films in box office receipts is becoming increasingly clear, with the influence of domestic animated films on the rise.

RECOMMEND





